PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'School of Medicine, Imperial College London, London, UK. florence.rodgers15@imperial.ac.uk.\', \'School of Medicine, Imperial College London, London, UK.\', \'Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.\', \'Department of Global Health & Development, London School of Hygiene and Tropical Medicine, London, UK.\', \'Oxford University Clinical Academic Graduate School, Oxford, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s13063-021-05024-y
?:hasPublicationType
?:journal
  • Trials
is ?:pmid of
?:pmid
?:pmid
  • 33451350
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.291
?:rankingScore_hIndex
  • 57
?:title
  • Missing clinical trial data: the evidence gap in primary data for potential COVID-19 drugs.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33451350>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33451350>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all